Latest Radiopharmacology Stories

Addition of Dr. Norman LaFrance strengthen further Jubilant DraxImage expertise  MONTREAL, Oct. 17, 2012 /PRNewswire/ - Jubilant DraxImage Inc. (hereinafter "JDI"), a Jubilant Life Sciences Company, is pleased to announce the appointment of Dr. Norman LaFrance as Vice President, Medical & Regulatory Affairs and Chief Medical Officer, Jubilant DraxImage Inc. with effect from October 16, 2012.  Dr. LaFrance has extensive and successful FDA and global clinical regulatory...

LUBBOCK, Texas, Oct. 9, 2012 /PRNewswire/ -- Positron Corporation, (OTCBB:POSC) a molecular imaging healthcare company, announces that their subsidiary, Manhattan Isotope Technology, LLC, has received an acknowledgment letter and Drug Master File (DMF) number assignment, from the United States Food & Drug Administration (FDA), for its Strontium-82 Drug Substance. Manhattan Isotope Technology (MIT) has received acknowledgment from the FDA for its Strontium-82 Drug Substance...

LUBBOCK, Texas, Sept. 27, 2012 /PRNewswire/ -- Positron Corporation (OTCBB:POSC), a molecular imaging healthcare company will be presenting at the 1(st) International Business Conference for Producers, Suppliers and Consumers of Isotope Products (1IBCI), which will take place in Moscow, Russia, October 1(st )- 3(rd), 2012. The 1IBCI conference, organized by Isotope Co., an entity within the Rosatom State Atomic Energy Corporation's (ROSATOM) Program "Radiation Technologies," will...

FARMINGTON, Conn., Sept. 24, 2012 /PRNewswire-iReach/ -- As the medical imaging industry approaches maturity in developed markets, imaging machine makers such as GE and Siemens AG are looking to bolster significant growth in the developing markets. Nontraditional uses for diagnostics and monitoring for both new therapies and minimally invasive procedures is expected to drive growth in the U.S., reports The Wall Street Journal. The market for contrast agents and radiopharmaceuticals is also...

DULLES, Va., Sept. 10, 2012 /PRNewswire/ -- IBA Molecular North America, Inc. (IBA Molecular), a leading manufacturer and distributor of PET imaging tracers, has announced the introduction of its Centers for Innovation, two unique facilities designed for advanced radiopharmaceutical contract development and manufacturing. The centers are located in Totowa and Somerset, New Jersey. Complementing these sites are IBA Molecular's production capabilities for isotopes such as I-124, F-18,...

BALTIMORE, Sept. 6, 2012 /PRNewswire/ -- Positron Corporation (OTCBB: POSC), - is pleased to announce that Jubilant DraxImage Inc. (hereinafter "JDI"), a Jubilant Life Sciences Company, and Positron Corporation (hereinafter "Positron"), have executed a Letter of Intent pertaining to: (a) Positron's supply of Active Pharmaceutical Ingredient (API) grade Sr-82 for the JDI Sr-82/Rb-82 generator; (b) JDI's and Positron's co-promotion of JDI Sr-82/Rb-82 generators to...

BERLIN, August 30, 2012 /PRNewswire/ -- Innovative medical research in Germany In April 2012, Indian MNC Piramal took over Bayer HealthCare's molecular-imaging pipeline and has since then been continuing research and development work on the acquired PET radiopharmaceuticals in its labs in Berlin. Speaking at a press conference Mr. Ajay Piramal, Chairman of Piramal Group commented on the strategy saying, "Molecular imaging is one of the key technologies paving the way to...

LUBBOCK, Texas, Aug. 22, 2012 /PRNewswire/ -- Positron Corporation, (OTCBB:POSC) a leading molecular imaging healthcare company, is pleased to announce the submission of a Drug Master File (DMF), with the Federal Drug Administration (FDA), for the production of Active Pharmaceutical Ingredient (API) grade strontium-82, through its wholly owned subsidiary Manhattan Isotope Technology, LLC. A Drug Master File (DMF) is a document submitted to the FDA, which contains complete...

CHICAGO, Aug. 20, 2012 /PRNewswire/ -- Positron Corporation (OTCBB: POSC) a leading molecular imaging healthcare company, is pleased to announce the FDA's marketing approval of The University of Texas Health Science Center at Houston (UTHealth) Coronary Flow Reserve (CFR) quantification software, cfrQuant(TM). The cfrQuant(TM) software was developed under the guidance of K. Lance Gould, M.D., and the Weatherhead PET Imaging Center of the UTHealth Medical School, with contributions of...

CHICAGO, Aug. 16, 2012 /PRNewswire/ -- Positron Corporation (OTCBB: POSC) a leading molecular imaging healthcare company is pleased to announce the use of their Attrius system at Caring Heart and Brain Imaging Inc., of Manasquan, New Jersey, which now offers Amyvid PET scans to identify the presence of plaque in the brain, which has been shown to be a precursor to Alzheimer's disease. Amyvid(TM) (Florbetapir F-18 Injection) is indicated for Positron Emission Tomography (PET) imaging...